Targeting sex steroid biosynthesis for breast and prostate cancer therapy
- PMID: 37684402
- DOI: 10.1038/s41568-023-00609-y
Targeting sex steroid biosynthesis for breast and prostate cancer therapy
Conflict of interest statement
Competing interests: M.P. receives funding and research support from Orion Pharma and Forendo Pharma, has a consultation agreement with Forendo Pharma (past) and Organon & Co (current), and co-supervises a Ph.D. student at Orion Pharma. M.H.T and P.H. declare no competing interests.
References
Publication types
LinkOut - more resources
Full Text Sources
